Saturday 17 October 2026
Export EMN’s income statement to Excel — free account
Eastman Chemical Company
EMN Basic Materials Specialty Chemicals
Eastman Chemical Company’s revenue for fiscal 2025 (year ended December 2025) was $8.8 billion, down 6.71% from fiscal 2024. In the quarter to June 2026, revenue grew 9.88%, EPS grew 31.2%, free cash flow grew 49.4% and total debt fell 6.90%, each against the same quarter a year earlier. Dividend growth for twenty-five consecutive years.
62.33
1.54
−2.41%
Follow EMN
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 7.32% | 6.63% | 7.97% | 12.08% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
5 | 5 | 5 | 5 | |
| 2.88% | 2.64% | 3.15% | 4.65% | ||
ROIC |
4.72% | 4.19% | 5.01% | 6.46% | |
Return on Tangible Assets |
6.22% | 5.72% | 7.05% | 9.48% | |
Average Days of Receivables |
56.20 | 51.42 | 41.66 | 51.53 | |
Free Cash Flow per Share |
4.72 | 4.36 | 3.70 | 3.45 | |
Free Cash Flow |
539.00 | 498.00 | 424.00 | 395.00 | |
Capital Expenditures |
(452.00) | (502.00) | (546.00) | (613.00) | |
| Other line items | |||||
Cash ROIC |
4.76% | 4.45% | 3.92% | 3.55% | |
Accounts Receivable Turnover |
6.55 | 6.98 | 8.06 | 6.93 | |
Accounts Payable Turnover |
3.45 | 3.48 | 3.20 | 3.48 | |
Inventory Turnover |
3.34 | 3.31 | 3.48 | 3.63 | |
Average Days of Payables |
106.63 | 105.22 | 109.16 | 97.80 | |
Days of Inventory on Hand |
107.96 | 109.43 | 104.62 | 101.52 | |
Tax Rate |
(0.18) | (0.12) | (0.16) | (0.18) | |
Research and Development Expense of Revenue |
2.77% | 2.87% | 2.91% | 2.91% | |
Selling, General and Administrative Expense of Revenue |
7.69% | 7.57% | 7.52% | 7.55% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
3.53 | 3.14 | 3.73 | 5.04 | |
Operating CF/Net income |
2.24 | 2.51 | 2.05 | 1.44 | |
Depreciation/Fixed assets |
0.09 | 0.09 | 0.09 | 0.09 | |
Capex/Depreciation |
(0.86) | (0.97) | (1.06) | (1.20) | |
Revenue per Share |
77.56 | 75.65 | 76.30 | 78.88 | |
Operating CF per Share |
8.67 | 8.76 | 8.46 | 8.81 | |
Capex per Share |
(3.95) | (4.40) | (4.76) | (5.36) | |
Capex to Sales |
0.05 | 0.06 | 0.06 | 0.07 |
Columns are period end dates